SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalMcKesson HBOC (MCK)


Previous 10 Next 10 
To: Wally Mastroly who wrote (137)10/25/1999 10:26:00 AM
From: epicure
   of 165
 
YAY

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: epicure who wrote (138)10/25/1999 12:55:00 PM
From: Wally Mastroly
   of 165
 
Also FWIW, from the Street.com:

thestreet.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Wally Mastroly who wrote (139)10/25/1999 1:27:00 PM
From: Dale Stempson
   of 165
 
Well it certainly appears there was plenty of fear out there with regards to today's earnings report. While it's great to see MCK move up this morning, I'm still cautious about where we'll end up over the very near-term. I hope the CC went well today and we'll be able to say goodbye forever to the high teens.

Regards - Dale

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Dale Stempson who wrote (140)12/13/1999 9:22:00 AM
From: Wally Mastroly
   of 165
 
MCK gets a plug:

cbs.marketwatch.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Wally Mastroly who wrote (141)12/15/1999 2:44:00 AM
From: w sun
   of 165
 
This guy seems to be on something. MCK sales has grown at > 30% rate over last 3 years. It has been hurt badly by HBO fiasco this year. But its earning is recovering:
1q 2q 3q(12/99) 4q(3/00) y00
.21 .25 .34 .47 1.27
Also, forecasted 5y eps growth is 23%. The days mck stays at $20 is numbered.(ws)

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: w sun who wrote (142)12/15/1999 9:03:00 AM
From: Rambi
   of 165
 
Some good news.....

biz.yahoo.com

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Rambi who wrote (143)12/15/1999 5:12:00 PM
From: Henk Wondergem
   of 165
 
NO reaction by the market yet????

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Henk Wondergem who wrote (144)12/15/1999 5:33:00 PM
From: Rambi
   of 165
 
No- and that's really discouraging. I guess everyone saw this at Yahoo:
Drug Distributors Fail to Soar on Retail Deals
By Michael Brick
TheStreet.com/NYTimes.com Staff Reporter
12/15/99 12:42 PM ET

Two pharmaceuticals distributors trumpeted new multi-year sales agreements with drugstore chains Wednesday. But the deals did little to cure the distributors' ills on Wall Street.

Bergen Brunswick, (BBC:NYSE - news), of Orange County, Calif., said it signed a five-year agreement to be New York-based Duane Reade's (DRD:NYSE - news) primary supplier of drugs and health care products. The deal is worth $200 million a year, the company said.

Separately, McKesson HBOC (MCK:NYSE - news) of San Francisco said it extended for six years a deal to serve as Youngstown, Ohio-based Phar-Mor's (PMOR:Nasdaq - news) primary supplier. That deal should generate $2 billion in revenue over its lifetime, the companies said.

Shares of Bergen gained 1/4, or 3%, to 8 1/16 by midday Wednesday, and shares of McKesson rose 1/4, or 1%, to 20 11/16. Phar-Mor shares gained 5/16, or 8%, to 2 15/16, but Duane Reade shares dropped 1/2, or 2%, to 22.

"It's nothing that I'm jumping up and down about," said Andrew Speller, analyst for A.G. Edwards. He has hold ratings on both distributors and doesn't cover the retailers. His firm co-managed a preferred stock offering for Bergen in May. "This kind of stuff happens all the time. In most other industries, people don't send out press releases when they sign supply agreements."

Both distributors have been looking for some good news this year. Bergen's stock is almost 30 points off a 52-week high of 37 3/4, and McKesson's is almost 70 points off a 52-week high of 89 3/4.

For McKesson, the deal with Phar-Mor may prove slightly more substantive than its previous arrangement with the retailer because it includes automation products, Speller said. The products -- with names like OmniLink and BakerAPS Pharmacy 2000 -- count pills and notify pharmacists if a patient's insurance won't pay for the drug his doctor prescribed.

That could increase profits at Phar-Mor by allowing the company to eliminate technicians, and the products carry a higher profit margin for McKesson, according to Speller.

"This is pretty much prototypical of what the wholesalers are trying to do," Speller said. "You make money selling pharmaceuticals on the wholesale side, but you make a lot more money offering these other services."

Share RecommendKeepReplyMark as Last Read


To: Rob Pierce who wrote ()1/11/2000 10:24:00 AM
From: Paul Lee
   of 165
 
McKesson HBOC, Inc., Signs Definitive Agreement to Sell Its Water Products Business to Groupe DANONE for $1.1 Billion
SAN FRANCISCO--(BUSINESS WIRE)--Jan. 11, 2000--McKesson HBOC, Inc. (NYSE:MCK - news; McKessonHBOC) announced today that it has signed a definitive agreement with the Groupe DANONE (NYSE:DA - news) whereby DANONE will purchase the McKesson Water Products Company, a subsidiary of McKessonHBOC, for a total consideration of $1.1 billion in cash.

The transaction has been approved by the Boards of Directors of both companies and is subject to regulatory review and other customary conditions.

The McKesson Water Products Company is the third-largest processor, marketer and distributor of bottled water in the United States. The company markets bottled water in 30 states under the Sparkletts©, Alhambra© and Crystal(TM) brands. McKesson Water Products has expected revenues of more than $380 million with an EBITDA margin of 22% in its fiscal year ended March 31, 1999.

``Given our strategic focus on improving healthcare quality and cost through our market-leading positions in healthcare information technology and supply management, McKesson Water Products was not a core business,' said John H. Hammergren and David L. Mahoney, McKessonHBOC co-presidents and co-chief executive officers.

``We believe that this transaction is in the best interests of both our shareholders and the Water Products Company employees who have created significant value in this business. We wish them well as they become a key element of DANONE's U.S. bottled water business

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Paul Lee who wrote (146)1/11/2000 10:26:00 AM
From: epicure
   of 165
 
Seems like a good move so far.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10